MoneyWorks4Me

Ajanta Pharma informs about newspaper advertisement

15 Oct 2026 Evaluate
Pursuant to Regulation 29 of the Listing Regulations, Ajanta Pharma has informed that a Meeting of the Board of Directors of the Company will be held on Friday, 30th October 2026, to consider and approve unaudited consolidated and standalone financial results of the Company for the second quarter and half year ended 30th September 2026.

The above information is a part of company’s filings submitted to BSE. 
Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1237.65
Cipla 1313.80
Lupin 1957.00
Zydus Lifesciences 1117.30
View more..